OTCM
VSMD
Market cap0USD
Oct 29, Last price
0.00USD
Name
Vasamed Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Key people
Paulita LaPlante
President and Chief Executive Officer and Director · since 1998
Kent Winger
Vice President - Operations · since 2006
Roberta Dircks
Chief Financial Officer, Vice President - Finance and Administration · since 2006
Terry Duesterhoeft
Vice President of Sales and Marketing · since 2004
Richard Egen
Director · since 1997
Andrew Jay
Director · since 2005
Charles Snead
Director · since 2000
Craig Walker
Director · since 2008
Valuation
No data to show